CLINICAL_TRIALS
trial_result
· 2022-08-04
Clinical Trial Update: Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL) [Phase 4]
Summary
Phase 4 randomized controlled trial investigating therapeutic escalation for moderate postoperative recurrence in Crohn's disease (POMEROL trial).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: Crohn Disease | Phase 4 | Status: UNKNOWN